[email protected]

Author: Khyati Patel

Before Your QA Meeting

Pharma Audits

Before Your QA Meeting: 10 Quality Signals Every Leader Should Track

April 23, 2026 No Comments

Evidence Collection Flaws That Trigger

GVP Audits

Evidence Collection Flaws That Trigger Escalated Observations in Hybrid Audits

April 21, 2026 No Comments

Visual Inspection 4.0

Pharma Audits

Visual Inspection 4.0: Machines That Never Miss a Defect (And Regulators Love It)

April 16, 2026 No Comments

Survive a Hybrid GMP Inspection

Pharmacovigilance Services

How to Survive a Hybrid GMP Inspection Without a Single Observation

April 14, 2026 No Comments

Digital Risk Management

Risk-Based Audits

RMP 2.0: Digital Risk Management Plans Every Clinical Team Should Be Using

April 9, 2026 No Comments

Biosimilars Under the Microscope

Pharmacovigilance Services

Biosimilars Under the Microscope: Post-Marketing Safety Shifts You Can’t Ignore

April 7, 2026 No Comments

Annex 15 Revision

Pharma Audits

Annex 15 Revision: Key Impacts on Qualification and Validation for GDP Operators

March 31, 2026 No Comments

Pharmacovigilance

Pharmacovigilance Services

Navigating Dual MHRA/EMA Pharmacovigilance Obligations Post-Windsor Framework

March 26, 2026 No Comments

GMP Annex 22

Pharmacovigilance Services

EU GMP Annex 22 (Artificial Intelligence): What GMP-Regulated Manufacturers Must Do Before the Effective Date

March 24, 2026 No Comments

EU Pharma Package

Pharma Audits

EU Pharma Package 2026: What It Means for GMP/GDP Operators Now

March 19, 2026 No Comments

Let’s build a GxP-compliant future together.

Have a project in mind?

Partner with us to elevate your quality systems, ensure compliance, and drive meaningful business transformation.

Built with passion and purpose. Helping you grow smarter, not harder.

QUICK LINKS

CONTACT US

[email protected]

Newsletter Signup

Subscribe to our newsletter for the latest insights

Copyright © 2026 Quality Vigilance Ltd | All Rights Reserved || Powered by Prabisha Consulting